Overview

Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
DateTitle 
11/21/16Computerworld Names Covance’s Dimitris Agrafiotis a Premier 100 Technology Leader
Agrafiotis’ Leadership in Bringing Xcellerate® Informatics to Market Demonstrates How Software Can Improve Health and Improve Lives BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 21, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company, is proud to announce that IDG’s Computerworld recently recognized Dimitris Agrafiotis, Ph.D., chief data officer and head of technology products ... 
Printer Friendly Version
11/01/16LabCorp is Scheduled to Present at the 2016 Credit Suisse Healthcare Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 1, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the 2016 Credit Suisse Healthcare Conference. LabCorp’s presentation is planned for Monday, November 7, 2016 at 12:30 PM (ET). A live audio webcast will be available via the Company website at www.labcorp.com and archived for replay. About LabCorp® Laboratory Corpo... 
Printer Friendly Version
10/26/16Laboratory Corporation of America® Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance
Q3 Net revenue of $2.4 billion, up 5% over last year Q3 Diluted EPS of $1.71, up 14% over last year Q3 Adjusted EPS of $2.25, up 9% over last year 2016 Adjusted EPS guidance updated to $8.70 - $8.90, up 10% to 13% over 2015 Adjusted EPS BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 26, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for t... 
Printer Friendly Version
10/25/16Covance Central Laboratory Services Ranks No. 1 in Global Investigator Satisfaction for the Third Consecutive Time
New study also shows that investigators are more willing to work with a sponsor when the sponsor chooses their preferred central lab BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 25, 2016-- An independent report has established that physician clinical-trial investigators identify Covance Central Laboratory Services as their "most preferred" central laboratory more than three times as often as the nearest competitor. Covance is the drug development business... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
LH (Common)
ExchangeNYSE
Price$126.38
Change Stock is Up 1.27
Intraday High$127.11
Intraday Low$123.41
Volume905,574
Data as of 12/07/16
4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2015 Annual Report

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release